REPORT ID 6622

EMEA (Europe, Middle East and Africa) Vaccine Adjuvants Market Report 2017

Publish Date
26-Dec-17
Pages
104
Format
Electronic (PDF)

In this report, the EMEA Vaccine Adjuvants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (Units), revenue (Million USD), market share and growth rate of Vaccine Adjuvants for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Vaccine Adjuvants market competition by top manufacturers/players, with Vaccine Adjuvants sales volume (Units), price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    SEPPIC
    SDA BIO
    Brenntag Biosector
    SPI Pharma
    MVP Laboratories
    Tj Kaiwei
    Novavax
    Zhuoyue
    Aphios

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Oral
    Subcutaneous
    Intramuscular
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Human Vaccine Adjuvants
    Veterinary Vaccine Adjuvants

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Vaccine Adjuvants Market Report 2017
1 Vaccine Adjuvants Overview
    1.1 Product Overview and Scope of Vaccine Adjuvants
    1.2 Classification of Vaccine Adjuvants
        1.2.1 EMEA Vaccine Adjuvants Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Vaccine Adjuvants Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Oral
        1.2.4 Subcutaneous
        1.2.5 Intramuscular
        1.2.6 Others
    1.3 EMEA Vaccine Adjuvants Market by Application/End Users
        1.3.1 EMEA Vaccine Adjuvants Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Human Vaccine Adjuvants
        1.3.3 Veterinary Vaccine Adjuvants
    1.4 EMEA Vaccine Adjuvants Market by Region
        1.4.1 EMEA Vaccine Adjuvants Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Vaccine Adjuvants (2012-2022)
        1.5.1 EMEA Vaccine Adjuvants Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Vaccine Adjuvants Revenue and Growth Rate (2012-2022)

2 EMEA Vaccine Adjuvants Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Vaccine Adjuvants Market Competition by Players/Manufacturers
        2.1.1 EMEA Vaccine Adjuvants Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Vaccine Adjuvants Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Vaccine Adjuvants Sale Price by Players (2012-2017)
    2.2 EMEA Vaccine Adjuvants (Volume and Value) by Type/Product Category
        2.2.1 EMEA Vaccine Adjuvants Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Vaccine Adjuvants Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Vaccine Adjuvants Sale Price by Type (2012-2017)
    2.3 EMEA Vaccine Adjuvants (Volume) by Application
    2.4 EMEA Vaccine Adjuvants (Volume and Value) by Region
        2.4.1 EMEA Vaccine Adjuvants Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Vaccine Adjuvants Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Vaccine Adjuvants Sales Price by Region (2012-2017)

3 Europe Vaccine Adjuvants (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Vaccine Adjuvants Sales and Value (2012-2017)
        3.1.1 Europe Vaccine Adjuvants Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Vaccine Adjuvants Revenue and Growth Rate (2012-2017)
    3.2 Europe Vaccine Adjuvants Sales and Market Share by Type
    3.3 Europe Vaccine Adjuvants Sales and Market Share by Application
    3.4 Europe Vaccine Adjuvants Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Vaccine Adjuvants Sales Volume by Countries (2012-2017)
        3.4.2 Europe Vaccine Adjuvants Revenue by Countries (2012-2017)
        3.4.3 Germany Vaccine Adjuvants Sales and Growth Rate (2012-2017)
        3.4.4 France Vaccine Adjuvants Sales and Growth Rate (2012-2017)
        3.4.5 UK Vaccine Adjuvants Sales and Growth Rate (2012-2017)
        3.4.6 Russia Vaccine Adjuvants Sales and Growth Rate (2012-2017)
        3.4.7 Italy Vaccine Adjuvants Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Vaccine Adjuvants Sales and Growth Rate (2012-2017)

4 Middle East Vaccine Adjuvants (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Vaccine Adjuvants Sales and Value (2012-2017)
        4.1.1 Middle East Vaccine Adjuvants Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Vaccine Adjuvants Revenue and Growth Rate (2012-2017)
    4.2 Middle East Vaccine Adjuvants Sales and Market Share by Type
    4.3 Middle East Vaccine Adjuvants Sales and Market Share by Application
    4.4 Middle East Vaccine Adjuvants Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Vaccine Adjuvants Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Vaccine Adjuvants Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Vaccine Adjuvants Sales and Growth Rate (2012-2017)
        4.4.4 Israel Vaccine Adjuvants Sales and Growth Rate (2012-2017)
        4.4.5 UAE Vaccine Adjuvants Sales and Growth Rate (2012-2017)
        4.4.6 Iran Vaccine Adjuvants Sales and Growth Rate (2012-2017)

5 Africa Vaccine Adjuvants (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Vaccine Adjuvants Sales and Value (2012-2017)
        5.1.1 Africa Vaccine Adjuvants Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Vaccine Adjuvants Revenue and Growth Rate (2012-2017)
    5.2 Africa Vaccine Adjuvants Sales and Market Share by Type
    5.3 Africa Vaccine Adjuvants Sales and Market Share by Application
    5.4 Africa Vaccine Adjuvants Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Vaccine Adjuvants Sales Volume by Countries (2012-2017)
        5.4.2 Africa Vaccine Adjuvants Revenue by Countries (2012-2017)
        5.4.3 South Africa Vaccine Adjuvants Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Vaccine Adjuvants Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Vaccine Adjuvants Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Vaccine Adjuvants Sales and Growth Rate (2012-2017)

6 EMEA Vaccine Adjuvants Manufacturers/Players Profiles and Sales Data
    6.1 SEPPIC
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Vaccine Adjuvants Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 SEPPIC Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 SDA BIO
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Vaccine Adjuvants Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 SDA BIO Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Brenntag Biosector
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Vaccine Adjuvants Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Brenntag Biosector Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 SPI Pharma
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Vaccine Adjuvants Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 SPI Pharma Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 MVP Laboratories
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Vaccine Adjuvants Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 MVP Laboratories Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Tj Kaiwei
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Vaccine Adjuvants Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Tj Kaiwei Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Novavax
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Vaccine Adjuvants Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Novavax Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Zhuoyue
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Vaccine Adjuvants Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Zhuoyue Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Aphios
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Vaccine Adjuvants Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Aphios Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview

7 Vaccine Adjuvants Manufacturing Cost Analysis
    7.1 Vaccine Adjuvants Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Vaccine Adjuvants

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Vaccine Adjuvants Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Vaccine Adjuvants Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Vaccine Adjuvants Market Forecast (2017-2022)
    11.1 EMEA Vaccine Adjuvants Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Vaccine Adjuvants Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Vaccine Adjuvants Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Vaccine Adjuvants Price and Trend Forecast (2017-2022)
    11.2 EMEA Vaccine Adjuvants Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Vaccine Adjuvants Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Vaccine Adjuvants Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Vaccine Adjuvants Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Vaccine Adjuvants Sales Forecast by Type (2017-2022)
    11.7 EMEA Vaccine Adjuvants Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer